Related Experiment Video
Updated: Sep 6, 2025

Identification of Sleeping Beauty Transposon Insertions in Solid Tumors using Linker-mediated PCR
Published on: February 1, 2013
Novel cancer gene discovery using a forward genetic screen in RCAS-PDGFB-driven gliomas
Holger Weishaupt1, Matko Čančer1, Gabriela Rosén1
1Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Background:
Malignant gliomas, the most common malignant brain tumors in adults, represent a heterogeneous group of diseases with poor prognosis. Retroviruses can cause permanent genetic alterations that modify genes close to the viral integration site.
Methods:
Here we describe the use of a high-throughput pipeline coupled to the commonly used tissue-specific retroviral RCAS-TVA mouse tumor model system. Utilizing next-generation sequencing, we show that retroviral integration sites can be reproducibly detected in malignant stem cell lines generated from RCAS-PDGFB-driven glioma biopsies.
Results:
A large fraction of common integration sites contained genes that have been dysregulated or misexpressed in glioma. Others overlapped with loci identified in previous glioma-related forward genetic screens, but several novel putative cancer-causing genes were also found. Integrating retroviral tagging and clinical data, Ppfibp1 was highlighted as a frequently tagged novel glioma-causing gene. Retroviral integrations into the locus resulted in Ppfibp1 upregulation, and Ppfibp1-tagged cells generated tumors with shorter latency on orthotopic transplantation. In human gliomas, increased PPFIBP1 expression was significantly linked to poor prognosis and PDGF treatment resistance.
Conclusions:
Altogether, the current study has demonstrated a novel approach to tagging glioma genes via forward genetics, validating previous results, and identifying PPFIBP1 as a putative oncogene in gliomagenesis.
Insights
Researchers identified a novel oncogene, PPFIBP1, in malignant gliomas using a retroviral tagging method. This discovery offers new insights into brain tumor development and potential therapeutic targets.
Area of Science:
- Neuro-oncology
- Genetics
- Cancer Biology
Background:
- Malignant gliomas are aggressive brain tumors with poor outcomes.
- Retroviruses can induce genetic changes near their integration sites, potentially driving cancer.
Purpose of the Study:
- To develop and utilize a high-throughput retroviral tagging system for identifying genes involved in glioma development.
- To discover novel oncogenes and validate known cancer-related genes in malignant gliomas.
Main Methods:
- Employed a RCAS-TVA mouse model and next-generation sequencing for retroviral integration site analysis.
- Generated malignant stem cell lines from RCAS-PDGFB-driven glioma biopsies.
- Integrated retroviral tagging data with clinical information.
Main Results:
- Identified numerous common retroviral integration sites, many overlapping with known dysregulated or previously screened glioma genes.
- Discovered novel putative cancer-causing genes, notably highlighting Ppfibp1.
- Demonstrated that retroviral integration into the Ppfibp1 locus increases its expression, leading to shorter tumor latency.
- Found that elevated PPFIBP1 expression in human gliomas correlates with poor prognosis and resistance to PDGF treatment.
Conclusions:
- Established a novel forward genetics approach for identifying glioma-associated genes.
- Validated previous findings in glioma genetics.
- Identified PPFIBP1 as a putative oncogene in gliomagenesis with clinical relevance.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...